News Center

Home page

Peak Report

News reports

Peak Pharmaceutical Becomes National Intellectual Property Demonstration Enterprise

Release time:

2020-07-31

News from our newspaper It is only one year since 2016 was identified as a national intellectual property advantage enterprise, and "Zhejiang Jianfeng Pharmaceutical Co., Ltd." has appeared in the list of national intellectual property demonstration enterprises in 2017 recently released by the State Intellectual Property Office. As a result, Jianfeng Pharmaceutical has become the first and only national intellectual property demonstration enterprise in Jinhua City.

12# November 12 , the State Intellectual Property Office issued a notice to announce the list of national intellectual property demonstration enterprises and advantageous enterprises in 2017 . After enterprise declaration, recommendation by provincial and municipal bureaus, examination by national bureaus, and public announcement, 182 national intellectual property demonstration enterprises and 816 national intellectual property advantage enterprises have been identified. Including Jianfeng Pharmaceutical, Zhejiang Province has been identified as a national intellectual property demonstration enterprise only 15 .

With the continuous development of enterprises in recent years, Jianfeng Pharmaceutical has set up a special working organization to cultivate and enhance intellectual property capabilities in terms of strategic management, creation, operation and protection of intellectual property rights, it has successively compiled and implemented 27 procedural documents and 36 forms such as "Intellectual Property Management Manual", "Intellectual Property Reward and Punishment System" and "Trade Secret Management System", and revised them in time according to policies and the current situation of the enterprise to ensure the compliance and effectiveness of the system operation. In 2012 and 2013 , Jianfeng Pharmaceutical was successively rated as a patent demonstration enterprise in Jinhua City and Zhejiang Province. won the third prize of Jinhua Patent Implementation Award in 2013 ; passed the certification of intellectual property management system in 2016 and was identified as a national intellectual property advantage enterprise. At present, Jianfeng Pharmaceutical has 140 domestic and foreign applications and 127 registered authorizations for various inventions, utility models and trademark intellectual property rights, including well-known trademarks in China, 2 well-known trademarks in Zhejiang Province and 5 well-known trademarks in Jinhua City. In terms of intellectual property operation, improvement of innovation efficiency, and promotion of property ownership and industrialization of innovation achievements, active attempts are also made.

Under normal circumstances, the construction of a national intellectual property advantage enterprise expires for three years, and only after the assessment reaches the standard can it be upgraded to a demonstration enterprise. However, it only took one year for Jianfeng Pharmaceutical to complete the leap from an "advantage enterprise" to a "demonstration enterprise. This indicates that the level of intellectual property creation, management, application and protection of Jianfeng Pharmaceutical has entered a higher level. It is understood that Jianfeng Pharmaceutical has achieved excellent results in the annual assessment of national intellectual property advantage enterprises, which is an important reason for this "jump. Through the implementation of the national standard of "enterprise intellectual property management standard" and the cultivation of advantageous enterprises and demonstration enterprises, Jianfeng pharmaceutical has realized the advanced development of "improving the foundation of intellectual property management, cultivating intellectual property advantages and forming comprehensive competitive advantages". It can not only protect itself, but also avoid infringing on the rights and interests of other enterprises, It provides strong support for the economic transformation and upgrading of enterprises, improving quality and efficiency. In addition, this time it has been identified as a national intellectual property demonstration enterprise, and Jianfeng Pharmaceutical will also receive a 30 yuan award from Jinhua City.

According to the requirements of the documents of the State Intellectual Property Office, the construction period of the national intellectual property demonstration enterprise in 2017 is from 2017 12 to 2020 11 . During this period, local intellectual property management departments should, in accordance with relevant requirements and combined with actual work, explore the establishment of a distinctive enterprise cultivation policy system, further improve the overall plan for the cultivation of demonstration enterprises and advantageous enterprises in the region, and clarify the phased tasks of cultivation. Increase investment, guarantee special funds, gather expert resources and support measures, and strengthen targeted guidance, service, supervision and inspection of enterprise intellectual property work. As a demonstration enterprise, Jianfeng Pharmaceutical will also further formulate a work plan for the construction of demonstration enterprises, establish and improve work leadership and overall coordination mechanisms, further strengthen the management and implementation of intellectual property strategies, increase guarantees, and ensure that the construction of demonstration enterprises achieves practical results and realizes knowledge The development goal of a strong enterprise with property rights. (Reporter Fu Yiwu)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页